We previously reported that tumor-specific Caveolin-1 (CAV1) was prognostic for both contralateral breast cancer (CAV1 in malignant cells) and locoregional recurrence (CAV1 in stromal cells) [13]. The gene discussed is CAV1; the disease is breast carcinoma.